April 20196Alex D'souzaManaging Editoreditor@Medicaltechoutlook.comEDITORIALMoving Toward Minimally Invasive ProceduresRising incidence of cardiovascular disorders represents one of the key factors that are driving the demand of cardiovascular devices. Catalyzed by unhealthy diets and sedentary lifestyles, the number of affected patients has increased across both developed and developing countries. According to the Centers for Disease Control and Prevention (CDC), coronary heart disease is the most common type of heart diseases which is responsible for over 370,000 deaths annually, in the U.S. alone. Common cardiovascular diseases include coronary artery diseases (CAD) such as angina and myocardial infarction (commonly known as a heart attack). Driven by the rising number of cardiac diseases, the global cardiovascular device market is currently witnessing rapid technological advancements. Moreover, the improvements in medical imaging and robotic-assisted surgeries have led physicians to leverage such devices (angiography balloon catheters, for instance) to find its way up in the healthcare landscape. Cardiac surgeons and patients have shifted their preference toward minimally-invasive procedures due to leftover scars and pain caused by traditional surgeries. This has had a major impact on the demand for point-of-care cardiovascular diagnostic equipment worldwide. Some of the major advantages of minimally-invasive surgeries include not requiring large incisions, and high hospitalization expenditure, while ensuing faster post-operative recovery compared to an open surgery. Other than this, increasing awareness about the various treatment options for cardiovascular diseases, rapid technological advancements, and changing lifestyles have also been boosting the growth of the cardiovascular devices market. However, stringent regulatory policies, which delays product launches, along with the high cost of instruments, lack of skilled professionals, and unfavorable market conditions for new players are the major factors that hinder the growth of the cardiovascular devices market. A number of companies have been receiving government approvals for the launch and commercialization of cardiovascular devices. Keeping track of the evolving trends in the cardiovascular device industry, this edition of Med Tech Outlook compiles the current practices that innovative companies in the space employ. We hope the valuable insights from industry thought-leaders and the cutting-edge solutions from leading as well as emerging companies featured in this edition will help you make informed decisions in your cardiovascular device endeavors. Let us know your thoughts!April - 05 - 2019, volume 03 - Issue 06 Published by ValleyMedia, Inc. Managing EditorAlex D'souzaEditorial StaffVisualizerIssac GeorgeRozarioSalesRich Gonsalvesrich@medicaltechoutlook.com510.972.5010Contact usEmailPhone:510 230 0396 Fax:510-894-8405sales@medicaltechoutlook.comeditor@medicaltechoutlook.commarketing@medicaltechoutlook.comMerlin WatsonSarah FernandesJustin GonsalvesJoe Philip Laura PintoJoshua Parker To subscribe to Government CIO OutlookVisit www.govciooutlook.com Copyright © 2019 ValleyMedia Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.*Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staff
< Page 5 | Page 7 >